Lysosomal membrane permeabilization in cell death: new evidence and implications for health and disease

Annals of the New York Academy of Sciences

Volumn 1371, Issue 1, 2016, Pages 30-44

  Serrano Puebla, Ana ^a   Boya, Patricia ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

autophagy; calpain; cathepsin; lysophagy; lysosomal damage

Indexed keywords

4 HYDROXYNONENAL; APOPTOSIS INDUCING FACTOR; CALPAIN; CASPASE; CATHEPSIN B; CATHEPSIN D; CATHEPSIN L; CYSTEINE PROTEINASE; CYTOCHROME C; HEAT SHOCK PROTEIN 70; HYDROLASE; HYDROXYL RADICAL; INFLAMMASOME; INTERLEUKIN 1BETA CONVERTING ENZYME; ISATUXIMAB; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MAGNETITE NANOPARTICLE; POMALIDOMIDE; PROTEIN AGGREGATE; PROTEIN BAX; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; TRIPEPTIDYL PEPTIDASE I;

ALZHEIMER DISEASE; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BACTERIAL INFECTION; BIOGENESIS; CANCER THERAPY; CELL DEATH; DISEASES; HEALTH; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUNTINGTON CHOREA; INFLAMMATION; LIPID COMPOSITION; LYSOSOME MEMBRANE; LYSOSOME STORAGE DISEASE; MEMBRANE PERMEABILITY; METABOLISM; NERVE CELL NECROSIS; NERVE DEGENERATION; NIEMANN PICK DISEASE; NONHUMAN; PARKINSON DISEASE; PYROPTOSIS; RETINA DEGENERATION; RETINA ISCHEMIA;

EID: 84977573474     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12966     Document Type: Article

References (96)

1. De Duve, C. & R. Wattiaux. 1966. Functions of lysosomes. Annu. Rev. Physiol. 28: 435–492.
2. Shen, H.M. & N. Mizushima. 2014. At the end of the autophagic road: an emerging understanding of lysosomal functions in autophagy. Trends. Biochem. Sci. 39: 61–71.
3. Boya, P., F. Reggiori & P. Codogno. 2013. Emerging regulation and functions of autophagy. Nat. Cell Biol. 15: 713–720.
4. Puertollano, R. 2014. mTOR and lysosome regulation. F1000Prime Rep. 6: 52.
5. Settembre, C. et al. 2013. Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat. Rev. Mol. Cell Biol. 14: 283–296.
6. Boya, P. & G. Kroemer. 2008. Lysosomal membrane permeabilization in cell death. Oncogene 27: 6434–6451.
7. Mindell, J.A. 2012. Lysosomal acidification mechanisms. Annu. Rev. Physiol. 74: 69–86.
8. Churchill, G.C. et al. 2002. NAADP mobilizes Ca(2+) from reserve granules, lysosome-related organelles, in sea urchin eggs. Cell 111: 703–708.
9. 2+ release channel from liver lysosomes of rats. J. Biol. Chem. 282: 25259–25269.
10. Faouzi, M. & R. Penner. 2014. Trpm2. Handb. Exp. Pharmacol. 222: 403–426.
11. Marschner, K. et al. 2011. A key enzyme in the biogenesis of lysosomes is a protease that regulates cholesterol metabolism. Science 333: 87–90.
12. Sardiello, M. et al. 2009. A gene network regulating lysosomal biogenesis and function. Science 325: 473–477.
13. Perera, R.M. et al. 2015. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism. Nature 524:361–365.
14. Luzio, J.P. et al. 2000. Lysosome–endosome fusion and lysosome biogenesis. J. Cell Sci. 113: 1515–1524.
15. Yu, L. et al. 2010. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 465: 942–946.
16. Rong, Y. et al. 2012. Clathrin and phosphatidylinositol-4,5-bisphosphate regulate autophagic lysosome reformation. Nat. Cell Biol. 14: 924–934.
17. Chang, J., S. Lee & C. Blackstone. 2014. Spastic paraplegia proteins spastizin and spatacsin mediate autophagic lysosome reformation. J. Clin. Invest. 124: 5249–5262.
18. Segatori, L. 2014. Impairment of homeostasis in lysosomal storage disorders. IUBMB Life 66: 472–477.
19. Boya, P. 2012. Lysosomal function and dysfunction: mechanism and disease. Antioxid. Redox Signal. 17: 766–774.
20. Nixon, R.A. 2013. The role of autophagy in neurodegenerative disease. Nat. Med. 19: 983–997.
21. Repnik, U., M. Hafner Cesen & B. Turk. 2014. Lysosomal membrane permeabilization in cell death: concepts and challenges. Mitochondrion 19: 49–57.
22. Kirkegaard, T. et al. 2010. Hsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathology. Nature 463: 549–553.
23. Bove, J. et al. 2014. BAX channel activity mediates lysosomal disruption linked to Parkinson disease. Autophagy 10: 889–900.
24. Guan, J.J. et al. 2015. DRAM1 regulates apoptosis through increasing protein levels and lysosomal localization of BAX. Cell Death Dis. 6: e1624.
25. Crighton, D. et al. 2006. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126: 121–134.
26. Terman, A. et al. 2006. Lysosomal labilization. IUBMB Life 58: 531–539.
27. Krenn, M.A. et al. 2015. Ferritin-stimulated lipid peroxidation, lysosomal leak, and macroautophagy promote lysosomal “metastability” in primary hepatocytes determining in vitro cell survival. Free Radic. Biol. Med. 80: 48–58.
28. Boya, P. et al. 2003. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J. Exp. Med. 197: 1323–1334.
29. Petersen, N.H. et al. 2010. Connecting Hsp70, sphingolipid metabolism and lysosomal stability. Cell Cycle 9: 2305–2309.
30. Nylandsted, J. et al. 2004. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J. Exp. Med. 200: 425–435.
31. Sahara, S. & T. Yamashima. 2010. Calpain-mediated Hsp70.1 cleavage in hippocampal CA1 neuronal death. Biochem. Biophys. Res. Commun. 393: 806–811.
32. Zhu, H., T. Yoshimoto & T. Yamashima. 2014. Heat shock protein 70.1 (Hsp70.1) affects neuronal cell fate by regulating lysosomal acid sphingomyelinase. J. Biol. Chem. 289: 27432–27443.
33. Gabande-Rodriguez, E. et al. 2014. High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type A. Cell Death Differ 21: 864–875.
34. Kreuzaler, P.A. et al. 2011. Stat3 controls lysosomal-mediated cell death in vivo. Nat. Cell Biol. 13: 303–309.
35. Arnandis, T. et al. 2012. Calpains mediate epithelial-cell death during mammary gland involution: mitochondria and lysosomal destabilization. Cell Death Differ. 19: 1536–1548.
36. Villalpando Rodriguez, G.E. & A. Torriglia. 2013. Calpain 1 induce lysosomal permeabilization by cleavage of lysosomal associated membrane protein 2. Biochim. Biophys. Acta 1833: 2244–2253.
37. Yamashima, T. 2013. Reconsider Alzheimer's disease by the ‘calpain-cathepsin hypothesis’—a perspective review. Prog. Neurobiol. 105: 1–23.
38. Yousefi, S. et al. 2006. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat. Cell Biol. 8: 1124–1132.
39. Norman, J.M., G.M. Cohen & E.T. Bampton. 2010. The in vitro cleavage of the hAtg proteins by cell death proteases. Autophagy 6: 1042–1056.
40. Fehrenbacher, N. et al. 2004. Sensitization to the lysosomal cell death pathway upon immortalization and transformation. Cancer Res. 64: 5301–5310.
41. Petersen, N.H. et al. 2013. Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase. Cancer Cell 24: 379–393.
42. Doerflinger, M., J.A. Glab & H. Puthalakath. 2015. BH3-only proteins: a 20-year stock-take. FEBS J. 282: 1006–1016.
43. Eno, C.O. et al. 2013. Noxa couples lysosomal membrane permeabilization and apoptosis during oxidative stress. Free Radic. Biol. Med. 65: 26–37.
44. Mannick, J.B. et al. 2001. S-Nitrosylation of mitochondrial caspases. J. Cell Biol. 154: 1111–1116.
45. Chaitanya, G.V. & P.P. Babu. 2008. Multiple apoptogenic proteins are involved in the nuclear translocation of apoptosis inducing factor during transient focal cerebral ischemia in rat. Brain Res. 1246: 178–190.
46. Yuste, V.J. et al. 2005. Cysteine protease inhibition prevents mitochondrial apoptosis-inducing factor (AIF) release. Cell Death Differ. 12: 1445–1448.
47. Galluzzi, L. et al. 2012. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 19: 107–120.
48. Duewell, P. et al. 2010. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464: 1357–1361.
49. Halle, A. et al. 2008. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9: 857–865.
50. Orlowski, G.M. et al. 2015. Multiple cathepsins promote Pro-IL-1beta synthesis and NLRP3-mediated IL-1beta activation. J. Immunol. 195: 1685–1697.
51. Chen, Y. et al. 2015. Endothelial Nlrp3 inflammasome activation associated with lysosomal destabilization during coronary arteritis. Biochim. Biophys. Acta 1853: 396–408.
52. Lage, S.L. et al. 2013. Cytosolic flagellin-induced lysosomal pathway regulates inflammasome-dependent and-independent macrophage responses. Proc. Natl. Acad. Sci. U.S.A. 110: E3321–E3330.
53. Schneider, J.L. & A.M. Cuervo. 2014. Autophagy and human disease: emerging themes. Curr. Opin. Genet. Dev. 26C: 16–23.
54. Kroemer, G. 2015. Autophagy: a druggable process that is deregulated in aging and human disease. J. Clin. Invest. 125: 1–4.
55. Rodriguez-Muela, N. & P. Boya. 2012. Axonal damage, autophagy and neuronal survival. Autophagy 8: 286–288.
56. Boya, P. et al. 2003. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 22: 3927–3936.
57. Hung, Y.H. et al. 2013. Spatiotemporally controlled induction of autophagy-mediated lysosome turnover. Nat. Commun. 4: 2111.
58. Maejima, I. et al. 2013. Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury. EMBO J. 32: 2336–2347.
59. Sargeant, T.J. et al. 2014. Stat3 controls cell death during mammary gland involution by regulating uptake of milk fat globules and lysosomal membrane permeabilization. Nat. Cell Biol. 16: 1057–1068.
60. Loison, F. et al. 2014. Proteinase 3–dependent caspase-3 cleavage modulates neutrophil death and inflammation. J. Clin. Invest. 124: 4445–4458.
61. Zhu, W. et al. 2015. Sensing cytosolic RpsL by macrophages induces lysosomal cell death and termination of bacterial infection. PLoS Pathog. 11: e1004704.
62. Bewley, M.A. et al. 2011. A cardinal role for cathepsin d in co-ordinating the host-mediated apoptosis of macrophages and killing of pneumococci. PLoS Pathog. 7: e1001262.
63. Laforge, M. et al. 2013. DRAM triggers lysosomal membrane permeabilization and cell death in CD4(+) T cells infected with HIV. PLoS Pathog. 9: e1003328.
64. Lipton, P. 2013. Lysosomal membrane permeabilization as a key player in brain ischemic cell death: a “lysosomocentric” hypothesis for ischemic brain damage. Transl. Stroke Res. 4: 672–684.
65. Nikoletopoulou, V. & N. Tavernarakis. 2014. Necrotic cell death in Caenorhabditis elegans. Methods Enzymol. 545: 127–155.
66. 2+, PIP2 and calpain responses prior to delayed neuronal death in monkeys. Eur. J. Neurosci. 8: 1932–1944.
67. Zhu, H. et al. 2012. Why are hippocampal CA1 neurons vulnerable but motor cortex neurons resistant to transient ischemia? J. Neurochem. 120: 574–585.
68. Chinskey, N.D., Q.D. Zheng & D.N. Zacks. 2014. Control of photoreceptor autophagy after retinal detachment: the switch from survival to death. Invest. Ophthalmol. Vis. Sci. 55: 688–695.
69. Rodriguez-Muela, N. et al. 2015. Lysosomal membrane permeabilization and autophagy blockade contribute to photoreceptor cell death in a mouse model of retinitis pigmentosa. Cell Death Differ. 22: 476–487.
70. Gonzalez, P. et al. 2012. Impairment of lysosomal integrity by B10, a glycosylated derivative of betulinic acid, leads to lysosomal cell death and converts autophagy into a detrimental process. Cell Death Differ. 19: 1337–1346.
71. Sizova, O.S. et al. 2014. Modulation of cellular signaling pathways in P23H rhodopsin photoreceptors. Cell Signal. 26: 665–672.
72. Parfitt, D.A. et al. 2014. The heat-shock response co-inducer arimoclomol protects against retinal degeneration in rhodopsin retinitis pigmentosa. Cell Death Dis. 5: e1236.
73. Dehay, B. et al. 2010. Pathogenic lysosomal depletion in Parkinson's disease. J. Neurosci. 30: 12535–12544.
74. Vila, M. et al. 2011. Lysosomal membrane permeabilization in Parkinson disease. Autophagy 7: 98–100.
75. Roczniak-Ferguson, A. et al. 2012. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci. Signal. 5: ra42.
76. Settembre, C. et al. 2011. TFEB links autophagy to lysosomal biogenesis. Science 332: 1429–1433.
77. Lee, J.H. et al. 2010. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141: 1146–1158.
78. Lee, J.K. et al. 2014. Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer's disease. J. Exp. Med. 211: 1551–1570.
79. Walls, K.C. et al. 2010. Lysosome dysfunction triggers Atg7-dependent neural apoptosis. J. Biol. Chem. 285: 10497–10507.
80. Menzies, F.M. et al. 2015. Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity. Cell Death Differ. 22: 433–444.
81. Micsenyi, M.C. et al. 2013. Lysosomal membrane permeability stimulates protein aggregate formation in neurons of a lysosomal disease. J. Neurosci. 33: 10815–10827.
82. Lieberman, A.P. et al. 2012. Autophagy in lysosomal storage disorders. Autophagy 8: 719–730.
83. Vidal-Donet, J.M. et al. 2013. Alterations in ROS activity and lysosomal pH account for distinct patterns of macroautophagy in LINCL and JNCL fibroblasts. PLoS One 8: e55526.
84. Pshezhetsky, A.V. 2015. Lysosomal storage of heparan sulfate causes mitochondrial defects; altered autophagy and neuronal death in the mouse model of mucopolysaccharidosis III type C. Autophagy DOI:10.1080/15548627.2015.1046671.
85. Platt, F.M. 2014. Sphingolipid lysosomal storage disorders. Nature 510: 68–75.
86. Elrick, M.J. et al. 2012. Impaired proteolysis underlies autophagic dysfunction in Niemann–Pick type C disease. Hum. Mol. Genet. 21: 4876–4887.
87. Sarkar, S. et al. 2013. Impaired autophagy in the lipid-storage disorder Niemann–Pick type C1 disease. Cell Rep. 5: 1302–1315.
88. Lloyd-Evans, E. et al. 2008. Niemann–Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat. Med. 14: 1247–1255.
89. Vitner, E.B. et al. 2010. Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease and in other sphingolipidoses. Hum. Mol. Genet. 19: 3583–3590.
90. Vitner, E.B. et al. 2014. RIPK3 as a potential therapeutic target for Gaucher's disease. Nat. Med. 20: 204–208.
91. Pacheco, F.J. et al. 2014. Docosahexanoic acid antagonizes TNF-alpha-induced necroptosis by attenuating oxidative stress, ceramide production, lysosomal dysfunction, and autophagic features. Inflamm. Res. 63: 859–871.
92. Groth-Pedersen, L. & M. Jaattela. 2013. Combating apoptosis and multidrug resistant cancers by targeting lysosomes. Cancer Lett. 332: 265–274.
93. Jiang, H. et al. 2015. SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide. Leukemia DOI:10.1038/leu.2015.240.
94. Wang, F. et al. 2013. Time resolved study of cell death mechanisms induced by amine-modified polystyrene nanoparticles. Nanoscale 5: 10868–10876.
95. Domenech, M. et al. 2013. Lysosomal membrane permeabilization by targeted magnetic nanoparticles in alternating magnetic fields. ACS Nano. 7: 5091–5101.
96. Granato, M. et al. 2013. HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma. Cell Death Dis. 4: e730.